What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

07.30.2021 - By DeviceTalks

Download our free app to listen on your phone

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone.

Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD.

Subscribe to this podcast on all major podcast apps.

More episodes from DeviceTalks